have discovered the underlying biology that identifies a subset of patients with acute lymphoblastic leukemia who have a higher risk version of the disease and are ... The development of CAR-T ...

In contrast, types of leukemia that have “acute” in their name (acute lymphocytic leukemia and ... and the stage (0 through IV) of your disease. Doctors can test for common and uncommon ...

Orca Bio announces it met the primary endpoint in its pivotal Phase 3 clinical study for its lead allogeneic T-cell immunotherapy, Orca-T.

NOTCH1 pathway activation contributes to the pathogenesis of over 60% of T-cell acute lymphoblastic leukemia (T-ALL ... between zebrafish and mammalian disease identified a common T-ALL gene ...

A couple who initially believed their son had been bitten by an insect in an Australian forest later discovered the cause of ...

Galinpepimut-S therapy showed specific T-Cell immune responses for patients with acute myeloid leukemia in remission ...

14, 2025 — A team of researchers has developed a new biomaterial with high potential in in the treatment of bone lesions or minimal residual disease ... B-cell acute lymphoblastic leukemia ...

With another trial win, Bristol Myers Squibb is touting Breyanzi as the CD19-directed CAR-T therapy with positive readouts in the most cancer types. | With another trial win, Bristol Myers Squibb is ...

Raising money to fight pediatric cancer was the focus of a Tuesday assembly at Grand Valley High School. Dan Kingsley, a childhood cancer survivor and cancer researcher at Case Western Reserve ...

The KU School of Medicine-Wichita Department of Pediatrics and Wesley Children’s Hospital recently announced an innovative ...